Saved in:
| Main Author: | |
|---|---|
| Format: | Recurso digital |
| Language: | English |
| Published: |
Zenodo
2025
|
| Subjects: | |
| Online Access: | https://doi.org/10.5281/zenodo.18022154 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Table of Contents:
- <p>This paper outlines a hypothesized Precision Phytotherapy Blueprint (B1.7) designed to target chronic inflammatory pain mechanisms as an alternative to conventional Percocet (Oxycodone/Acetaminophen). By integrating Mitragynine (MOR partial agonist), Beta-Caryophyllene (CB2 agonist), and Curcumin (COX-2 inhibitor) into a high-bioavailability nanodelivery matrix, we propose a synergistic analgesic effect with a reduced side-effect profile. This document serves as a pre-experimental protocol with placeholders for future clinical validation.</p>